CVS Generic Drug Charges

DEFENDANT NAME: CVS
STOCK SYMBOL:
CASE NUMBER: 1:16-cv-00046-S-PAS
CASE NAME:
COURT: U.S. District Court for the District of Rhode Island
PRACTICE AREA: Pharmaceutical Fraud
STATUS: Active
CLASS PERIOD:
LEAD PLAINTIFF DEADLINE:
DATE FILED: 02/01/16
COURT LOCATION:

Hagens Berman filed a complaint earlier this year stating that for years, CVS knowingly submitted false and artificially inflated prices for generic drugs to TPPs, seeking to hide the fraudulent, over-instated charges via its Health Savings Pass (HSP) program, which the lawsuit dubs “the vehicle for its fraud.”

According to the lawsuit, “big-box” retailers with pharmacy departments, such as Wal-Mart and Target, began offering hundreds of generic prescription drugs at significantly reduced prices in 2006. In November 2008, CVS responded by introducing its HSP program, which provided special pricing for approximately 400 generic prescription medications to individuals who paid an annual membership fee.
 
According to the complaint, CVS commonly submits electronic claims for payment to TPPs when it fills prescriptions, and is required to state accurately its usual and customary price for every dispensing event, which is generally defined as the cash price to the general public for the same drug. The amount collected by CVS may not exceed CVS’s usual and customary price.
 
CVS intended that the HSP program would hide its true usual and customary prices from TPPs to reap what the suit calls “ill-gotten gains.”
 
By submitting false and inflated usual and customary prices to third-party payors, CVS knowingly and wrongfully overcharged TPPs amounts that exceeded the HSP drug prices available to the general public for the same drugs, according to the suit, in many cases by more than three or four times the usual and customary price from November 2008 to the present.


Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.

Back to all cases

Case videos

Case Gallery

Case Timeline

03/31/18: Judge Grants Motion for Amended Complaint

Judge Smith's order grants the firm's motion to file an amended complaint on behalf of plaintiffs, adding RICO claims against CVS and certain pharmacy benefit managers (PBMs). Read the order here »

11/01/16: Judge Denies CVS’s Motion to Dismiss

A federal judge upheld a class-action lawsuit brought by third-party payors (TPPs) against CVS Health Corporation, denying CVS’s motion to dismiss the suit that accuses it of overcharging TPPs by up to four times the customary amount for generic prescription drugs, according to Hagens Berman.
 
In Judge William E. Smith’s opinion and order issued through the U.S. District Court for the District of Rhode Island on Nov. 1, 2016, he allowed consumer protection and unjust enrichment claims to proceed, stating that “Plaintiffs have sufficiently alleged a fraudulent scheme.”